TEMPE, Ariz., Oct. 16, 2014 /PRNewswire-iReach/ — PROTEOR USA, LLC a developer of next-generation prosthetic devices announced today CE Mark approval for its International lineup of prosthetic feet. The CE Mark identifies that PROTEOR USA and its products are in compliance with all safety requirements established by the European Union.

Currently distributing in Australia with an exclusive distribution agreement with OPC Health and in Canada with OrtoPed, the completion of this approval provides PROTEOR USA significant growth and expansion opportunity in the UK and Mainland Europe. Additionally, there are discussions with numerous international distributors already in progress.

J. Blount Swain, President of PROTEOR USA, LLC said “This approval is key for reaching our international awareness and expansion goals.” He added, “The global demand for our products has been extremely positive. This approval paves the way for our strategic launch into selective UK and European markets, with a patient-first focus on comfort, performance and safety.”

PROTEOR USA is a full service manufacturer of next-­generation prosthetic devices. (http://abilitydynamics.com) which offers customers a range of quality products and services to suit their needs. PROTEOR USA understanding and experience in the Industry is unparalleled.

Photos/Multimedia Gallery Available: http://www.abilitydynamics.com/prosthetists/

Media Contact: Holly Sanger, PROTEOR USA, 480-361-1303, hsanger@abilitydynamics.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com